Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Report: 3D Bioprinting Market Will Be Worth $1.3B by 2021

By MarketsandMarkets | February 1, 2017

3D bioprinting market worth 1,332.6 million USD by 2021. 

According to a new market research report published by MarketsandMarkets, the global 3D bioprinting market is expected to reach $1.3 billion by 2021, at CAGR of 26.5% from 2016 to 2021.

Key factors such as rising demand for organ transplantation, growing R&D in 3D bioprinting, increasing public and private investments in research, and rising use of 3D bioprinting in drug discovery are driving the growth of this market. However, the limitations of biomaterial-based products, lack of complete automation in 3D bioprinting, and socio-ethical concerns related to the use of 3D bioprinted products are the major challenges in this market.

By technology, the global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser, and magnetic 3D bioprinting. The microextrusion 3D bioprinting technology is estimated to command the largest share of the market in 2016, due to its affordability, among other factors.

On the basis of application, the market is segmented into clinical applications (including skin, bone & cartilage, and blood vessels) and research applications (including drug research, regenerative medicine, and 3D cell culture).

On the basis of procedure, the market is segmented into thoracotomy and minimally invasive surgeries. The The research applications segment holds the largest share in the 3D bioprinting market; it is projected to witness high growth during the forecast period. Increasing initiatives by market players and university scientists in the 3D bioprinting field form the major factor driving the growth of this segment.

Based on material, the 3D bioprinting market is further segmented into extracellular matrices, hydrogels, living cells, and biomaterials. The living cells segment is expected to account for the largest share of the market in 2016. Increasing R&D initiatives for the use of living cells in 3D bioprinting form one of the major factors driving the growth of the market.

As of 2016, North America holds the largest share of the global 3D bioprinting market, followed by Europe. However, the Asia-Pacificmarket is expected to grow at the highest CAGR from 2016 to 2021. A number of factors such as increase in overall and stem cell research activity, growing demand for organ transplantation, and rising initiatives by market players are propelling the growth of the Asia-Pacific 3D bioprinting market.

As of 2015, the 3D bioprinting market is dominated by Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), and Nano3D Biosciences, Inc. (U.S.). Other players in this market include Cyfuse Biomedical K.K. (Japan), BioBots (U.S.), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (U.K.), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany).    

(Source: PR Newswire)


Filed Under: Drug Discovery

 

Related Articles Read More >

Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
Labcorp widens precision oncology toolkit, aims to speed drug-trial enrollment
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE